ALG vs NBIX · P/E 23, rev $1.63B vs P/E 45, rev $2.36B
Alamo Group Inc (ALG) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Alamo Group Inc (ALG) is a farm & heavy construction machinery company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALG revenue for 2024-12-31 was $1.63B. Net income was $115.9M. Revenue was down 3.6% from 2023-12-31 to 2024-12-31. ALG currently screens at market cap $2.72B and trailing P/E 23.3.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
ALG currently screens at market cap $2.72B and trailing P/E 23.3. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the ALG and NBIX stock pages for the full models.
Not investment advice.